Abstract:Vaccination is the most effective method for the prevention of COVID-19 caused by SARS-CoV-2, which is still a global epidemic. However, the evolution of SARS-CoV-2 is so rapid that various variants, including the Alpha, Beta, Gamma, Delta, and Omicron variants, have emerged, lowering the protection rate of vaccines and even resulting in breakthrough infections. Additionally, some rare but severe adverse reactions induced by COVID-19 vaccines may raise safety concerns and hinder vaccine promotion; however, clinical studies have shown that the benefits of vaccination outweigh the risks caused by adverse reactions. Current vaccines approved with emergency use authorization (EUA) were originally adaptive for adults only, and infants, children, and adolescents are not included. New-generation vaccines are needed to overcome the challenges of limited adaptive age population, breakthrough infection (mainly due to virus variant emergencies), and critical adverse reactions. Fortunately, some advances in COVID-19 vaccines have been obtained regarding enlarged adaptive populations for clinical applications, such as the Pfizer/BioNTech vaccine and the Moderna vaccine. In this article, we provide a review on the challenges and recent advancements in COVID-19 vaccines. The development of next-generation COVID-19 vaccines should lay emphasis on the expansion of adaptive age populations in all individuals, the induction of immune responses to viral variants, the avoidance or alleviation of rare but potentially critical adverse reactions, and the discovery of subunit vaccines with adjuvants encapsulated in nanoparticles.

Review of Progress in New-Coronavirus Detection and Vaccine Research

Current status of coronavirus disease 2019 vaccine research based on bibliometric analysis

Coronavirus vaccine development: from SARS and MERS to COVID-19

Progress in SARS-CoV-2, Diagnostic and Clinical Treatment of COVID-19

Research Progress on a SARS-CoV-2 Vaccine in China

Evaluation of Immunoprotection Against Coronavirus Disease 2019: Novel Variants, Vaccine Inoculation, and Complications

Research progress and challenges to coronavirus vaccine development

The COVID-19 Vaccines: Recent Development, Challenges and Prospects

Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects

COVID-19 in early 2021: current status and looking forward

COVID‐19 vaccine: recent advancements and future prospects

The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines

Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19)

COVID-19: Coronavirus Vaccine Development Updates

An updated review of SARS-CoV-2 detection methods in the context of a novel coronavirus pandemic

Nano Vaccines and Nano Materials for Vaccines

A review of the safety and efficacy of current COVID-19 vaccines

Challenges and Recent Advancements in COVID-19 Vaccines

Advances in the Design and Development of SARS-CoV-2 Vaccines

Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: A systematic review

The Role of SARS-CoV-2 N Protein in Diagnosis and Vaccination in the Context of Emerging Variants: Present Status and Prospects